No abstract available
Keywords:
Acinetobacter; COVID-19; SARS-CoV-2; co-infection; drug resistance; secondary infection.
MeSH terms
-
Acinetobacter Infections* / drug therapy
-
Acinetobacter Infections* / epidemiology
-
Acinetobacter baumannii*
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use
-
COVID-19*
-
Drug Resistance, Multiple, Bacterial
-
Humans
-
Microbial Sensitivity Tests
-
Pandemics